Results 111 to 120 of about 23,301 (196)

Cost-effectiveness analysis of ibrutinib plus venetoclax for relapsed or refractory mantle cell lymphoma in China and the United States. [PDF]

Front Public Health
He J, Liu X, Yang Q.
europepmc   +1 more source

Cyclin-Dependent Kinase-9 and Oxidative Phosphorylation Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma. [PDF]

Cancer Res Commun
Roleder C, Zhao X, Lam V, Shen H, Dominguez EC, Chen C, Rodriguez-Rodriguez S, Wang L, Phillips T, Xia Z, Danilov AV.   +10 more
europepmc   +1 more source

Clinical characteristics, treatment patterns, and survival in mantle cell lymphoma: a real-world cohort. [PDF]

Front Oncol
de la Hoz C, Hurtado-Otiz A, Licht-Ardila M, Cantillo A, Silva A, Herrera L, Alvarez P, Vega Jiménez OD, Fonseca J, Mendoza-Monsalve A, Avila JA, Manrique-Hernández EF.   +11 more
europepmc   +1 more source

Appendiceal Intussusception Secondary to Mantle Cell Lymphoma: A Report of a Rare Case. [PDF]

Cureus
Miyata N, Asomah F.
europepmc   +1 more source

Mantle Cell Lymphoma Presenting as a Primary Cutaneous Mass: A Case Report. [PDF]

Acta Derm Venereol
Wang Y, Duan Y, Qin C, Wang Y, Ding X.
europepmc   +1 more source

Multifaceted cfDNA profiling in mantle cell lymphoma. [PDF]

Blood Adv
Sworder BJ, Herrera AF.
europepmc   +1 more source

Case Report: Durable remission of intraocular mantle cell lymphoma after CD19 CAR-T therapy. [PDF]

Front Immunol
Bienert-García Á, Arruabarrena C, Asencio-Duran M, Arias MM, Baumann T, Izquierdo AR, Sánchez-Pina JM, López-Muñoz N, Gil-Alós D, Saez-Marín AJ, Calbacho M, Martínez-López J, Jiménez-Ubieto A.   +12 more
europepmc   +1 more source

Advances in biomarkers for mantle cell lymphoma in the era of targeted therapies. [PDF]

Haematologica
Loh Z, Yeh P, Keane C, Hawkes EA.
europepmc   +1 more source

Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. [PDF]

Blood Cancer J
Che Y, Liu Y, Yao Y, Hill HA, Li Y, Cai Q, Yan F, Jain P, Wang W, Rui L, Wang M.   +10 more
europepmc   +1 more source

Correction to 'Mucin 20 Modulates Proteasome Capacity Through c-Met Signalling to Increase Carfilzomib Sensitivity in Mantle Cell Lymphoma'. [PDF]

J Cell Mol Med
europepmc   +1 more source